Create a group of reviewers who will extensively review the methods used in experimentation and take further governmental action if required. Reviewers group will consist of members from the FDA and the NIH.

Regulate products created using the CRISPR-Cas9 system and experimentation in humans and animal subjects as needed and currently regulated by the FDA.

FDA should create new applications that need to be approved prior to experimentation to allow for approval to engineer new cas variants.